日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced

贫血的影响以及恩格列净对射血分数降低的心力衰竭的作用:EMPEROR-Reduced 的研究结果

João Pedro Ferreira, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Tomoko Iwata, Afshin Salsali, Cordula Zeller, Stuart J Pocock, Faiez Zannad, Milton Packer0

Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial

地区和种族对射血分数降低的心力衰竭患者对恩格列净反应的影响:EMPEROR-Reduced 试验

Carolyn S P Lam, João Pedro Ferreira, Egon Pfarr, David Sim, Hiroyuki Tsutsui, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Naveed Sattar, Subodh Verma, Martina Brueckmann, Janet Schnee, Daniel Cotton, Faiez Zannad, Milton Packer5

Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial

预测慢性心力衰竭发病率和死亡率的新型生物标志物驱动预后模型:EMPEROR-Reduced 试验

Stuart J Pocock, João Pedro Ferreira, John Gregson, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Nicholas D Gollop, Tomoko Iwata, Martina Brueckmann, James L Januzzi, Adriaan A Voors, Faiez Zannad, Milton Packer5

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced

恩格列净在治疗各种肾功能类型的心力衰竭时对心脏和肾脏的益处:EMPEROR-Reduced 的见解

Faiez Zannad, João Pedro Ferreira, Stuart J Pocock, Cordula Zeller, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Sibylle Jenny Hauske, Martina Brueckmann, Egon Pfarr, Janet Schnee, Christoph Wanner, Milton Packer4